RAMM Pharma Corp. (CSE:RAMM)
Canada flag Canada · Delayed Price · Currency is CAD
0.0150
0.00 (0.00%)
Apr 20, 2026, 9:04 AM EST

RAMM Pharma Revenue

RAMM Pharma had revenue of 212.72K CAD in the quarter ending January 31, 2026, a decrease of -78.94%. This brings the company's revenue in the last twelve months to 2.56M, down -41.70% year-over-year. In the fiscal year ending October 31, 2025, RAMM Pharma had annual revenue of 3.36M, down -22.60%.

Revenue (ttm)
2.56M
Revenue Growth
-41.70%
P/S Ratio
0.70
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.79M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Oct 31, 20253.36M-981.34K-22.60%
Oct 31, 20244.34M-723.29K-14.28%
Oct 31, 20235.07M1.17M29.96%
Oct 31, 20223.90M-218.63K-5.31%
Oct 31, 20214.12M-1.33M-24.40%
Oct 31, 2020 Pro Pro Pro
Oct 31, 2019 Pro Pro Pro
Oct 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ayurcann Holdings 31.28M
CanadaBis Capital 15.08M
Aion Therapeutic 1.47M
Genix Pharmaceuticals 68.00
Adastra Holdings 16.86M
Vencanna Ventures 2.75M
Revenue Rankings